Fig. 4From: Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveyPPE, Testing, and New Treatment Availability. Distribution of practices patterns and treatment types utilized in three geographic regions including, the US, Latin America, and Europe. There use a low use rate for Remdesivir or Tocilizumab, across all three regions; the majority of respondents report availability of PPE and COVID testing, on-site, across all three regionsBack to article page